Risk factors of hepatic function alterations in hospitalized adult patients treated with short-term parenteral nutrition receiving the same lipid composition at the same dose

Table 6 Multiple lineal regressions: differences between liver parameter variations and risk factors (p < 0.1)

Variable	GGT variation		AP variation		ALT variation		Bilirubin total variation
Variable	B [95% CI]	p	B [95% CI]	p	B [95% CI]	p	B [95% CI]	p
Surgery	1.05 [0.29–1.80]	0.007	0.18 [0.14–0.84]	0.006			2.00 [0.14–0.40]	0.014
Days in study	0.08 [0.03–0.13]	0.003	0.12 [0.18–0.17]	0.000			0.10 [−0.01–0.21]	0.072
Cancer	1.06 [0.27–1.84]	0.009	0.178 [−0.15–0.69]	0.060
Infection	0.44 [−0.01–0.88]	0.056	0.162 [0.04–0.68]	0.027	0.08 [0.01–0.16]	0.036
CRP			0.001 [0.00–0.006]	0.035
Leucocytes							0.15 [−0.12–0.29]	0.064
R²	0.150		0.523		0.050		0.089

CI confidence interval (μkat/L), GGT Gamma-glutamyl transferase (μkat/L), AP Alkaline phosphatase (μkat/L), ALT Alanine aminotransferase; B: constant in the model R² determination coefficient Creatinine, glucose and Intensive care unit stay do not feature in this model. Bold type indicates significance
Bold means statistically significant

ISSN: 1476-511X